Gland Pharma

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue1,0611,1211,0761,0741,094
Expenses760.20740.98681.72682.75731.20
EBITDA342.05421.61456.21437.84413.59
EBIT301.23379.99412.44394.77369.82
Profit Before Tax300.31379.82394.13391.32362.39
Net Profit222.92281.71295.12290.00269.26
Financial Ratios
Operating Profit Margin33.80%39.66%45.13%42.49%39.81%
Net Profit Margin22.03%26.50%29.20%28.15%25.92%
Earning Per Share (Diluted)13.5317.1017.9117.6016.34
Dividends Per Share0.000.000.000.000.00